
Chinese General Practice ›› 2016, Vol. 19 ›› Issue (29): 3624-3628.DOI: 10.3969/j.issn.1007-9572.2016.29.025
Previous Articles Next Articles
Published:2016-10-15
Online:2026-01-26
基金资助:JIANG Chun-xia, XU Yong. Research Progress of the Relationship between Type 2 Diabetes and Polychlorinated Biphenyls[J]. Chinese General Practice, 2016, 19(29): 3624-3628.
蒋春霞, 徐勇. 多氯联苯与2型糖尿病关系的研究进展[J]. 中国全科医学, 2016, 19(29): 3624-3628.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.3969/j.issn.1007-9572.2016.29.025
| [1]EVERETT C J,THOMPSON O M.Associations of dioxins,furans and dioxin-like PCBs with diabetes and pre-diabetes:is the toxic equivalency approach useful?[J].Environ Res,2012,118:107-111. [2]BABENKO A P,POLAK M,CAVE H,et al.Activating mutations in the ABCC8 gene in neonatal diabetes mellitus[J].N Engl J Med,2006,355(5):456-466. [3]AIRAKSINEN R,RANTAKOKKO P,ERIKSSON J G,et al.Association between type 2 diabetes and exposure to persistent organic pollutants[J].Diabetes Care,2011,34(9):1972-1979. [4]FAROON O,RUIZ P.Polychlorinated biphenyls:new evidence from the last decade[J].Toxicol Ind Health,2015.[Epub ahead of print]. [5]CARPENTER D O.Exposure to and health effects of volatile PCBs[J].Rev Environ Health,2015,30(2):81-92. [6]ASANTE K A,ADU-KUMI S,Nakahiro K,et al.Human exposure to PCBs,PBDEs and HBCDs in Ghana:temporal variation,sources of exposure and estimation of daily intakes by infants[J].Environ Int,2011,37(5):921-928. [7]GRIMM F A,HU D,KANIA-KORWEL I,et al.Metabolism and metabolites of polychlorinated biphenyls[J].Crit Rev Toxicol,2015,45(3):245-272. [8]CRINNION W J.Polychlorinated biphenyls:persistent pollutants with immunological,neurological,and endocrinological consequences[J].Altern Med Rev,2011,16(1):5-13. [9]TAYLOR K W,NOVAK R F,ANDERSON H A,et al.Evaluation of the association between persistent organic pollutants(POPs) and diabetes in epidemiological studies:a national toxicology program workshop review[J].Environ Health Perspect,2013,121(7):774-783. [10]TURYK M,ANDERSON H A,KNOBELOCH L,et al.Prevalence of diabetes and body burdens of polychlorinated biphenyls,polybrominated diphenyl ethers,and p,p’-diphenyldichloroethene in Great Lakes sport fish consumers[J].Chemosphere,2009,75(5):674-679. [11]SILVERSTONE A E,ROSENBAUM P F,WEINSTOCK R S,et al.Polychlorinated biphenyl(PCB) exposure and diabetes:results from the Anniston Community Health Survey[J].Environ Health Perspect,2012,120(5):727-732. [12]李文龙.中国青年人群血清中PCBs残留特征及规律研究[D].哈尔滨:哈尔滨工业大学,2012. [13]SONG Y,CHOU E L,BAECKER A,et al.Endocrine-disrupting chemicals,risk of type 2 diabetes,and diabetes-related metabolic traits:a systematic review and meta-analysis[J].J Diabetes,2016,8(4):516-532. [14]LEE D H,STEFFES M W,SJODIN A,et al.Low dose of some persistent organic pollutants predicts type 2 diabetes:a nested case-control study[J].Environ Health Perspect,2010,118(9):1235-1242. [15]LEE D H,STEFFES M W,SJODIN A,et al.Low dose organochlorine pesticides and polychlorinated biphenyls predict obesity,dyslipidemia,and insulin resistance among people free of diabetes[J].PLoS One,2011,6(1):e15977. [16]KANAGAWA Y,MATSUMOTO S,KOIKE S,et al.Association of clinical findings in Yusho patients with serum concentrations of polychlorinated biphenyls,polychlorinated quarterphenyls and 2,3,4,7,8-pentachlorodibenzofuran more than 30 years after the poisoning event[J].Environ Health,2008,7:47. [17]WANG S L,TSAI P C,YANG C Y,et al.Increased risk of diabetes and polychlorinated biphenyls and dioxins:a 24-year follow-up study of the yucheng cohort[J].Diabetes Care,2008,31(8):1574-1579. [18]WU H,BERTRAND K A,CHOI A L,et al.Persistent organic pollutants and type 2 diabetes:a prospective analysis in the nurses’ health study and meta-analysis[J].Environ Health Perspect,2013,121(2):153-161. [19]COLLINS A J,FOLEY R N,CHAVERS B,et al.United States Renal Data System 2011 Annual Data Report:Atlas of chronic kidney disease & end-stage renal disease in the United States[J].Am J Kidney Dis,2012,59(1 Suppl 1):A7,e1-420. [20]EVERETT C J,THOMPSON O M.Dioxins,furans and dioxin-like PCBs in human blood:causes or consequences of diabetic nephropathy?[J].Environ Res,2014,132:126-131. [21]LIND P M,VAN BAVEL B,SALIHOVIC S,et al.Circulating levels of persistent organic pollutants(POPs) and carotid atherosclerosis in the elderly[J].Environ Health Perspect,2012,120(1):38-43. [22]LONGNECKER M P,KLEBANOFF M A,BROCK J W,et al.Polychlorinated biphenyl serum levels in pregnant subjects with diabetes[J].Diabetes Care,2001,24(6):1099-1101. [23]DONAT-VARGAS C,GEA A,SAYON-OREA C,et al.Association between dietary intakes of PCBs and the risk of obesity:the SUN project[J].J Epidemiol Community Health,2014,68(9):834-841. [24]汤金梅,李文,解雨春,等.多氯联苯118对大鼠甲状腺自身免疫反应的影响[J].江苏医药,2013,39(8):869-871,封2. TANG J M,LI W,XIE Y C,et al.Effects of polychlorinated biphenyl 118 on thyroid autoimmunity in rats[J].Jiangsu Medical Journal,2013,39(8):869-871,Inside front cover. [25]杨慧,许波进,郑旭琴,等.多氯联苯118引起大鼠甲状腺炎症反应的研究[J].南京医科大学学报(自然科学版),2015,35(5):622-625. YANG H,XU B J,ZHENG X Q,et al.A study of polychlorinated biphenyl 118 induced inflammation reaction in rat thyroid[J].Acta Universitatis Medicinalis Nanjing(Natural Science),2015,35(5):622-625. [26]茅晓东,李兴佳,韦晓,等.PCB-118对大鼠胰岛细胞的生长抑制作用[J].江苏医药,2015,41(22):2650-2653. MAO X D,LI X J,WEI X,et al.Effects of polychlorinated biphenyl 118 on INS-1 pancreatic beta cells in rats[J].Jiangsu Medical Journal,2015,41(22):2650-2653. [27]何平,阮晓倩,丁晶莹,等.PCB153对INS-1细胞毒性作用及机制[J].中国公共卫生,2013,29(1):76-78. HE P,RUAN X Q,DING J Y,et al.Toxic effect and its mechanism of PCB153 on INS-1 cells[J].Chinese Journal of Public Health,2013,29(1):76-78. [28]陶鸿,易丽娴,孙中文,等.多氯联苯(PCB1254)诱导胰岛细胞凋亡的机制研究[J].南京医科大学学报(自然科学版),2015,35(3):346-351. TAO H,YI L X,SUN Z W,et al.Apoptosis induced by polychlorinated biphenyls(PCB1254) in islet cells[J].Acta Universitatis Medicinalis Nanjing(Natural Science),2015,35(3):346-351. [29]GRAY S L,SHAW A C,GAGNE A X,et al.Chronic exposure to PCBs(Aroclor 1254) exacerbates obesity-induced insulin resistance and hyperinsulinemia in mice[J].J Toxicol Environ Health,2013,76(12):701-715. [30]ARREBOLA J P,GONZALEZ-JIMENEZ A,FORNIELES-GONZALEZ C,et al.Relationship between serum concentrations of persistent organic pollutants and markers of insulin resistance in a cohort of women with a history of gestational diabetes mellitus[J].Environ Res,2015,136:435-440. [31]李文,汤金梅,解雨春,等.多氯联苯118对大鼠胰岛素敏感性影响的研究[J].中华糖尿病杂志,2013,5(10):614-617. LI W,TANG J M,XIE Y C,et al.Effects of polychlorinated biphenyl 118 on the insulin sensitivity in Wistar rats[J].Chinese Journal of Diabetes Mellitus,2013,5(10):614-617. [32]SUGANO T,YANAGITA T,YOKOO H,et al.Enhancement of insulin-induced PI3K/Akt/GSK-3beta and ERK signaling by neuronal nicotinic receptor/PKC-alpha/ERK pathway:up-regulation of IRS-1/-2 mRNA and protein in adrenal chromaffin cells[J].J Neurochem,2006,98(1):20-33. [33]FISCHER L J,WAGNER M A,MADHUKAR B V.Potential involvement of calcium,CaM kinase Ⅱ,and MAP kinases in PCB-stimulated insulin release from RINm5F cells[J].Toxicol Appl Pharmacol,1999,159(3):194-203. [34]WANG J,LYU X,DU Y.Inflammatory response and insulin signaling alteration induced by PCB77[J].J Environ Sci(China),2010,22(7):1086-1090. [35]MESNIER A,CHAMPION S,LOUIS L,et al.The transcriptional effects of PCB118 and PCB153 on the liver,adipose tissue,muscle and colon of mice:highlighting of Glut4 and Lipin1 as main target genes for PCB induced metabolic disorders[J].PLoS One,2015,10(6):e0128847. [36]DAVIS B K,WEN H,TING J P.The inflammasome NLRs in immunity,inflammation,and associated diseases[J].Annu Rev Immunol,2011,29:707-735. [37]MEIGS J B,LARSON M G,FOX C S,et al.Association of oxidative stress,insulin resistance,and diabetes risk phenotypes:the Framingham Offspring Study[J].Diabetes Care,2007,30(10):2529-2535. [38]LIN M,WU T,SUN L,et al.Aroclor 1254 causes atrophy of exocrine pancreas in mice and the mechanism involved[J].Environ Toxicol,2016,31(6):671-678. [39]BAKER N A,ENGLISH V,SUNKARA M,et al.Resveratrol protects against polychlorinated biphenyl-mediated impairment of glucose homeostasis in adipocytes[J].J Nutr Biochem,2013,24(12):2168-2174. [40]KARLAGANIS G,MARIONI R,SIEBER I,et al.The elaboration of the ‘Stockholm convention’ on persistent organic pollutants(POPs):a negotiation process fraught with obstacles and opportunities[J].Environ Sci Pollut Res Int,2001,8(3):216-221. |
| [1] | XIANG Tianle, ZHOU Na, LI Fang, CAO Meijuan. Research Progress on Assessment Methods of 24-hour Movement Behaviors in Children [J]. Chinese General Practice, 2026, 29(06): 760-766. |
| [2] | WANG Lina, LEI Jingshu, LI Kuibao, WANG Ruiying, LI Xinmiao, WANG Fangfang, GUO Xiaorong, NIU Ruihao, ZHAO Wei, ZHOU Fangfang, ZHAO Jingjing, LEE CHONGYOU. Review on Inflammatory Response in Patients with Acute Myocardial Infarction [J]. Chinese General Practice, 2026, 29(06): 790-801. |
| [3] | SHI Jiaqi, WANG Yuxin, LUO Jiani, JIANG Qi, WU Shanyu, JIN Toufeng. Factors Influencing Symptom Clusters in Patients with Gastrointestinal Cancers: a Scoping Review [J]. Chinese General Practice, 2026, 29(05): 668-675. |
| [4] | TIAN Ziwei, YANG Zhilan, ZHAO Huimin, ZHAI Yanping, LI Hongyan, DU Miao, JIN Yuanyuan, SONG Zeyu. Frailty in Patients with Knee Osteoarthritis: a Scoping Review [J]. Chinese General Practice, 2026, 29(05): 676-680. |
| [5] | CAO Xinyang, WANG Yang, JIN Hua, YU Dehua, YANG Hui, LIU Xiaoyun, XU Yanli. Factors Influencing the Development of Research Capabilities in General Practice: a Scoping Review [J]. Chinese General Practice, 2026, 29(04): 444-456. |
| [6] | WANG Yiheng, XU Xiaoming, XIA Yunlong, XIA Linying, HAN Xue, GUO Yongzhen, LIU Quanchi, YAN Wenjun. Progress in Pharmacotherapy of Heart Failure with Preserved Ejection Fraction [J]. Chinese General Practice, 2026, 29(03): 403-408. |
| [7] | JIANG Xiaorui, YAN Yuyao, WEI Jingjing, QIAO Lijie, PENG Guangcao, ZHU Mingjun. Systematic Review of Risk Prediction Models for Concurrent Heart Failure with Coronary Heart Disease [J]. Chinese General Practice, 2026, 29(03): 393-402. |
| [8] | LIU Yan, YUAN Yanling, LING Rong, WANG Lanyun, SUN Li. Scoping Review of Telemedicine Application in Cardiac Rehabilitation for Coronary Heart Disease Patients [J]. Chinese General Practice, 2025, 28(36): 4640-4647. |
| [9] | SUN Jiaying, ZHOU Pengxiang, XIA Yu, YAN Ming, ZHOU Xinmei, WU Lingyan, TONG Yuling, ZHAO Yang, XU Zhijie. Interpretation of a Position Statement from an Italian Scientific Consortium: Medication Review and Deprescribing [J]. Chinese General Practice, 2025, 28(36): 4550-4557. |
| [10] | WANG Yi, CHENG Jinxiang, ZHAO Xianchao, REN Jiafeng, ZHANG Liping, DONG Menglong, LIN Zhifeng, SU Changjun. Research Progress on Drug-related Rapid Eye Movement Sleep Behavior Disorder [J]. Chinese General Practice, 2025, 28(35): 4511-4516. |
| [11] | LI Mingyue, TANG Haoqing, ZHENG Huixian, ZHANG Xiaotian, LIU Xiaoyun. Exploring the Concept of the Quality of Primary Health Care: a Systematic Review [J]. Chinese General Practice, 2025, 28(34): 4300-4310. |
| [12] | HUANG Xintao, CHEN Mo, WANG Junyu, ZHANG Chen, DENG Huisheng. Research on Education of Rural-oriented Medical Students in China: a Systematic Review [J]. Chinese General Practice, 2025, 28(34): 4290-4299. |
| [13] | HE Yuling, LIN Meiqun, LUO Huiyu, HUANG Wenting, JIANG Liqin, ZHU Hongyu. Systematic Review of Guidelines for the Management of Patients with Cancer Pain [J]. Chinese General Practice, 2025, 28(33): 4199-4205. |
| [14] | WANG Mengqi, LIANG Moxuan, LI Zeyuan, GUO Yuting, CHENG Jingmin. Effectiveness of Intermittent Fasting in Patients with Type 2 Diabetes Mellitus: a Scoping Review [J]. Chinese General Practice, 2025, 28(33): 4234-4240. |
| [15] | GAO Jiaxin, ZHOU Ruihan, WANG Fangfang, PANG Rizhao, ZHANG Anren. Advances in Dietary Restriction on the Regulation of Organismal Immune Function [J]. Chinese General Practice, 2025, 28(32): 4102-4109. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||